TUMOUR - STROMA RATIO
The tumour-stroma ratio (TSR) is a diagnostic tool for overall and disease free survival in different epithelial cancer types. The TSR is easy to determine on H&E stained tissue sections in 1-2 minutes.
The TSR is based on the amount of stroma present within the primary tumour. This parameter distinguishes tumours with a high stroma percentage and low stroma percentage in two categories. To learn more about scoring the TSR, watch the instruction video.
A New Chapter: UNITED II
Building on the success of the UNITED study, we are excited to launch UNITED II. This next phase will further explore and validate the prognostic and predictive value of the tumor-stroma ratio (TSR), bringing us one step closer to clinical implementation. With new insights and collaborations, UNITED II marks an important step in translating research into practice—improving personalized treatment for cancer patients. Stay tuned for updates as we embark on this new chapter!
Changing of the Guard: Welcoming Floor Heilijgers
We welcome Floor Heilijgers as our new PhD candidate! She will coordinate UNITED II, focusing on the predictive value of the TSR and its clinical implementation.
Arteficial Intelligence
Artificial intelligence (AI) is transforming digital pathology, enabling deeper tissue analysis and the identification of novel biomarkers.